Navigation Links
Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
Date:11/6/2013

ing resultsUrologyPatients with Peyronie's Disease 

Injectable Pentoxifyline Solution 

$500 M

POC studies in first half 2014; pursue commercialization strategy pending resultsPainRenal-Compromised Patients with Osteoarthritis, Joint Pain, or Inflammation

Impracor 

10% Ketoprofen Cream

$500 M

POC studies in select patient populations in 2014; begin out-licensing to pharmacies pending outcome of resultsSeelhorst continued, "Because of the near-term opportunities in the Ophthalmology therapy area, Imprimis has already begun to build a world-class commercialization team to execute in this specialized market. This team brings a wealth of experience from giants in the industry in developing and commercializing ophthalmic drugs." 

Imprimis' new strategy will be supported by clinical data to either support a 505(b)(2) development program or to give sufficient clinical confidence to a prescribing physician that their patients will benefit from the proposed therapy choice.  To support these clinical-development efforts, Imprimis has hired a Clinical Project Manager to develop and execute proof-of-concept studies for its ophthalmic, wound management and urology products.

As part of Imprimis' shift in strategic direction, Imprimis plans to consider alternative commercialization pathways for Impracor, which may include an improvement of its formulation and the licensing of such a formulation to a network of partner pharmacies.  As a result of careful consideration of the totality circumstances surrounding Impracor, the current Impracor Phase 3 clinical program has been discontinued.

With the adoption of Imprimis' new strategic initiatives, projected cash burn is expected to decrease by more than $7.5 million over the next 12 months as compared with its previous estimates.
"We believe that our reduced burn rate and the near term commercialization of some of our key
'/>"/>

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... 2015 Cardinal Health today announced the completion ... distributor of generic pharmaceuticals, over-the-counter medications and related products ... owned by Court Square Capital Partners. The $1.115 billion ... new debt.  Headquartered in ... revenues of approximately $450 million in 2014. There are ...
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp (OTCQB: ... present live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be ... to ask the company questions in real-time - both ... "virtual trade booth." If attendees are not able to ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... Ga., June 14, 2011 Cardinal Health today opened ... further expanding its nationwide capability to manufacture molecular imaging ... treatment of cancer, neurological disorders and heart disease. ... Positron Emission Tomography (PET) molecular imaging agents, one of ...
... June 14, 2011 Orthopedics This Week announced today ... News to supply Orthopedics This Week, the #1 source ... terminal subscribers including some of the most prominent investors ... The Bloomberg network includes portfolio managers, central bankers, finance ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3Orthopedics This Week Now on Bloomberg 2
(Date:7/6/2015)... ... July 06, 2015 , ... ... nurses or midwives, yet there is a large gap between the unmet health ... required to improve health outcomes and reduce unnecessary or ineffective treatments or procedures. ...
(Date:7/6/2015)... ... ... Olive Fertility Centre is proud to announce that Olive medical director Dr. ... the department of Family Practice. , “This award is a real honour,” says Dr ... is changing so rapidly and we are also developing new models of patient-centred care ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the highest regarded provider ... Walk-In Urgent Care to offer on-site health screenings. These ultrasound screenings detect early ... affordable and accurate and run about an hour long with same day results. ...
(Date:7/6/2015)... ... ... Health care systems and genomics projects have generated massive patient data sets ... this “Big Data” to improve health and cut costs is now on the horizon, ... Health System in New York City. Physicians will have these new capabilities within two ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, ... to reduce their risk of having a fracture through the bone health screenings conducted ... Day. , “We are participating because our residents need this information to remain independent ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2
... following is a,statement by Mark J. Feldman, DMD, ... 70 percent of the U.S. population now receives,optimally ... news from the Centers for Disease,Control and Prevention ... optimally fluoridated water. We know from years of ...
... Hospital Arrives in Sichuan Province; Second Shipment of,Medical ... 10 -- AmeriCares is continuing its efforts to,provide ... Province and in areas most affected by Cyclone ... announced it has,delivered a second field hospital to ...
... Observances to Highlight Benefits of Family Planning, UNITED ... will observe World Population Day on 11 July by,emphasizing ... communities and nations, and by underlining the need to ... theme of World Population Day 2008, "Family Planning: It,s ...
... Record Inc. announces a,family of software solutions for ... first application, EmergenKey, allows a person to keep ... contact information on,their iPhone in the event something ... EmergenKey uses patent pending technologies,to automatically report to ...
... Injections helped restore damaged muscle in mice, researchers report ... are reporting that they,ve managed to repair damaged muscle ... injecting them with specialized stem cells from skeletal muscle. ... to humans with the disease, said study author Amy ...
... , Brush your teeth twice a day! Any ... only way to banish the bacteria that cause caries. Yet ... and gets uneven ?and the problem is that dental plaque ... professional cleaning services, removing plaque and discoloration with abrasive prophylactic ...
Cached Medicine News:Health News:AmeriCares Meets Long-Term Health Needs of Disaster Victims in China and Myanmar 2Health News:AmeriCares Meets Long-Term Health Needs of Disaster Victims in China and Myanmar 3Health News:World Population Day 2008 2Health News:Life Record Inc. Announces EmergenKey, My Life Record Family and Personal Edition for the iPhone on the Apple App Store 2Health News:Stem Cells Hold Promise for Muscular Dystrophy 2Health News:Polished to perfection 2
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
Medicine Products: